US › Healthcare

Integra LifeSciences Holdings (IART)

US · Healthcare · Medical Devices

$17.90+0.11%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$418.8M
Revenue YoY
+0.8%
Net profit
$4.5M
Profit YoY
+100.9%
EPS
$0.45
EPS estimate
$0.48
Net margin
1.1%

EPS came in at 0.45 against a street estimate of 0.48 — a miss of 6.2%.

Key statistics

Market cap
$1.29B
Forward P/E
6.8
P/B
1.24
Book value
$13.39
EPS (TTM)
$-0.09
52-week high
$20.49
52-week low
$8.70
50-day MA
$17.60
200-day MA
$13.32
Beta
1.22

Analyst view

Analysts rate Integra LifeSciences Holdings a hold (3 buy, 5 hold, 4 sell out of 12) with an average price target of $18.67.

Shareholding

Insiders
14.29%
Institutions
100.15%

Largest institutional holders

FundStake
BlackRock Inc13.26%
Rubric Capital Management LP9.97%
Vanguard Group Inc9.27%
Paradigm Capital Management, Inc.5.16%
Vanguard Portfolio Management, LLC4.74%
Morgan Stanley - Brokerage Accounts4.61%
Fuller & Thaler Asset Management Inc4.54%
Amvescap Plc.4.48%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Integra LifeSciences Holdings — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.